Journal ArticleDOI
A team‐based approach to patients in cardiogenic shock
Jacob A. Doll,Jacob A. Doll,E. Magnus Ohman,E. Magnus Ohman,Manesh R. Patel,Manesh R. Patel,Carmelo A. Milano,Joseph G. Rogers,David Wohns,Navin K. Kapur,Sunil V. Rao,Sunil V. Rao +11 more
TLDR
A multidisciplinary cardiogenic shock team is recommended to guide the rapid and efficient use of these available treatments, making time‐dependent decision‐making more challenging.Abstract:
Cardiogenic shock is a common clinical condition with high in-hospital mortality. Early application of appropriate interventions for cardiogenic shock-including medical therapies, revascularization, temporary hemodynamic support devices, and durable mechanical circulatory support-may improve outcomes. The number and complexity of therapies for cardiogenic shock are increasing, making time-dependent decision-making more challenging. A multidisciplinary cardiogenic shock team is recommended to guide the rapid and efficient use of these available treatments. © 2015 Wiley Periodicals, Inc.read more
Citations
More filters
Journal ArticleDOI
Simultaneous Venoarterial Extracorporeal Membrane Oxygenation and Percutaneous Left Ventricular Decompression Therapy with Impella Is Associated with Improved Outcomes in Refractory Cardiogenic Shock.
Sandeep M. Patel,Jerry Lipinski,Sadeer G. Al-Kindi,Toral R. Patel,Petar Saric,Jun Li,Fahd Nadeem,Thomas Ladas,Amer Alaiti,Ann Phillips,Benjamin Medalion,Salil V. Deo,Yakov Elgudin,Marco A. Costa,Mohammed Najeeb Osman,Guilherme F. Attizzani,Guilherme H. Oliveira,Basar Sareyyupoglu,Hiram G. Bezerra +18 more
TL;DR: In the largest US-based retrospective study, the addition of Impella to VA-ECMO for patients with refractory cardiogenic shock was associated with lower all-cause 30 day mortality, lower inotrope use, and comparable safety profiles as compared with VA- ECMO alone.
Journal ArticleDOI
Percutaneous Mechanical Circulatory Support Devices in Cardiogenic Shock
Aditya Mandawat,Sunil V. Rao +1 more
TL;DR: A consensus multidisciplinary approach that combines expertise from interventional cardiologists, heart failure specialists, cardiac surgeons, and cardiac anesthesiologists may help pair the right patient with the right device at the right time.
Journal ArticleDOI
Veno-Arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock: An Introduction for the Busy Clinician.
TL;DR: Extracorporeal membrane oxygenation has evolved, from a therapy that was selectively applied in the pediatric population in tertiary centers, to more widespread use in diverse forms of cardiopulmon...
Journal ArticleDOI
Predictors of 30-Day Mortality in Patients With Refractory Cardiogenic Shock Following Acute Myocardial Infarction Despite a Patent Infarct Artery
TL;DR: Systolic blood pressure, creatinine clearance, and number of vasopressors are significant predictors of mortality in patients with persistent vasopressor-dependent cardiogenic shock following acute MI despite a patent infarct artery.
Journal ArticleDOI
Management of cardiogenic shock complicating acute myocardial infarction: A review
TL;DR: An update on the currently available treatment options for CS complicating MI, including inotropes and vasopressor, coronary revascularization, mechanical circulatory support devices, mechanical complications, and long‐term outcomes is discussed.
References
More filters
Journal ArticleDOI
ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation
Stefan James,Dan Atar,Luigi P. Badano,Carina Blomström Lundqvist,Michael A. Borger,Anthony H. Gershlick,Kurt Huber,Peter Jüni,Mattie J. Lenzen,Kenneth W. Mahaffey,Marco Valgimigli +10 more
TL;DR: The once-in-a-lifetime treatment with Abciximab Intracoronary for acute coronary syndrome and a second dose intravenously for atrial fibrillation is recommended for adults with high blood pressure.
Journal ArticleDOI
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
Patrick T. O'Gara,Frederick G. Kushner,Deborah D. Ascheim,Donald E. Casey,Mina K. Chung,James A. de Lemos,Steven M. Ettinger,James C. Fang,Francis M. Fesmire,Barry A. Franklin,Christopher B. Granger,Harlan M. Krumholz,Jane A. Linderbaum,David A. Morrow,L. Kristin Newby,Joseph P. Ornato,Narith N. Ou,Martha J. Radford,Jacqueline E. Tamis-Holland,Carl L. Tommaso,Cynthia M. Tracy,Y. Joseph Woo,David Zhao +22 more
TL;DR: The 2017-18 FAHA/FACC/FAHA Education and Research Grants will be focused on advancing the profession’s understanding of central nervous system disorders and the management of post-traumatic stress disorder.
Journal ArticleDOI
Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Js. Hochman,La. Sleeper,John G. Webb,Timothy A. Sanborn,Harvey D. White,JD Talley,Christopher E. Buller,Alice K. Jacobs,James Slater,Jacques Col,Sonja M. McKinlay,Thierry H. LeJemtel +11 more
TL;DR: In patients with cardiogenic shock, emergency revascularization did not significantly reduce overall mortality at 30 days, but after six months there was a significant survival benefit, and earlyRevascularization should be strongly considered for patients with acute myocardial infarction complicated by cardiogenesis.
Journal ArticleDOI
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary
Patrick T. O'Gara,Frederick G. Kushner,Deborah D. Ascheim,Donald E. Casey,Mina K. Chung,James A. de Lemos,Steven M. Ettinger,James C. Fang,Francis M. Fesmire,Barry A. Franklin,Christopher B. Granger,Harlan M. Krumholz,Jane A. Linderbaum,David A. Morrow,L. Kristin Newby,Joseph P. Ornato,Narith N. Ou,Martha J. Radford,Jacqueline E. Tamis-Holland,Carl L. Tommaso,Cynthia M. Tracy,Y. Joseph Woo,David Zhao +22 more
TL;DR: This guideline makes more liberal use of summary recommendation tables (with references that support LOE) to serve as a quick reference (e.g. in PubMed), and more liberalUse of summaryRecommendations.
Journal ArticleDOI
Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
Holger Thiele,Uwe Zeymer,Franz-Josef Neumann,Miroslaw Ferenc,Hans-Georg Olbrich,Jörg Hausleiter,Gert Richardt,Marcus Hennersdorf,Klaus Empen,Georg Fuernau,Steffen Desch,Ingo Eitel,Rainer Hambrecht,Jörg Fuhrmann,Michael Böhm,Henning Ebelt,Steffen Schneider,Gerhard Schuler,Karl Werdan +18 more
TL;DR: The use of intraaortic balloon counterpulsation did not significantly reduce 30-day mortality in patients with cardiogenic shock complicating acute myocardial infarction for whom an early revascularization strategy was planned.